A molecular substance that occurs naturally in humans and rats was found to 'substantially reduce' brain damage after an acute stroke and contribute to a better recovery, according to a newly released animal study. The study was the first ever to show that the peptide AcSDKP provides neurological protection when administered one to four hours after the onset of an ischemic stroke.